PIC
ELV icon

PCJ Investment Counsel’s Elevance Health ELV Stock Holding History

PCJ Investment Counsel’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,000
Closed -$1.54M – 80
2022
Q4 		$1.54M Buy
+3,000
New +$1.52M 0.67% 52
2022
Q3 		– Sell
-5,000
Closed -$2.41M – 73
2022
Q2 		$2.41M Buy
+5,000
New +$2.47M 1.19% 32

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PCJ Investment Counsel's ELV Position: Q1 2023 in Review

PCJ Investment Counsel sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 3,000 shares — an estimated $1.54M sold.

PCJ Investment Counsel first reported a position in ELV in Q2 2022 and held it in 2 quarters. The position peaked at $2.41M in Q2 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • PCJ Investment Counsel reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • PCJ Investment Counsel sold 3,000 Elevance Health shares in Q1 2023, an estimated $1.54M.
  • PCJ Investment Counsel first reported a position in Elevance Health in Q2 2022 and held it in 2 quarters.
  • PCJ Investment Counsel's Elevance Health position peaked at $2.41M in Q2 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on PCJ Investment Counsel's 13F filing for Q1 2023, filed 5 May 2023.